AEROCHAMBER PLUS® FLOW-VU® AVHC CLINICAL EVIDENCE SUMMARY
Only AEROCHAMBER PLUS® FLOW-VU® chambers were equivalent to the reference device data listed in virtually all innovator inhalers currently approved in the US and European markets. Differences in chamber design, materials and function mean that chambers should not be automatically considered interchangeable. Learn more.
VALVED HOLDING CHAMBERS ARE NOT ALL EQUIVALENT IN PERFORMANCE AND AS A RESULT SHOULD NOT BE REGARDED AS INTERCHANGEABLE
Only AEROCHAMBER PLUS® FLOW-VU® chambers were equivalent to the reference device data listed in virtually all innovator inhalers currently approved in the US and European markets. Differences in chamber design, materials and function mean that chambers should not be automatically considered interchangeable. Learn more.
>DIFFERENT CHAMBERS DELIVER DIFFERENT AMOUNTS OF MEDICATION WHICH CAN LEAD TO MEANINGFUL DIFFERENCES IN CLINICAL PERFORMANCE
The author found that it was unequivocal that differences exist between different chambers which in a number of cases are sufficiently large that meaningful and overt clinical differences would be anticipated as a result. Learn more.
A COMPARATIVE ANALYSIS OF CHANGES IN PMDI DRUG DOSE DELIVERY BEFORE AND AFTER DETERGENT COATING USING FIVE ANTISTATIC VALVED HOLDING CHAMBERS
Some “antistatic” valved holding chambers (aVHC) have poor antistatic properties and should therefore be considered non-antistatic and primed. Differences in antistatic properties are an important cause of the large performance differences between aVHCs. Learn more.
If you have a question that was not answered here, please contact us.
